作者：
Alka,Dwivedi [1]
;
Atharva,Karulkar [1]
;
Sarbari,Ghosh [1]
;
Srisathya,Srinivasan [1]
;
Bajarang Vasant,Kumbhar [2]
;
Ankesh Kumar,Jaiswal [1]
;
Atish,Kizhakeyil [1]
;
Sweety,Asija [1]
;
Afrin,Rafiq [1]
;
Sushant,Kumar [1]
;
Albeena,Nisar [3]
;
Deepali Pandit,Patil [3]
;
Minal Vivek,Poojary [4]
;
Hasmukh,Jain [3]
;
Shripad D,Banavali [3]
;
Steven L,Highfill [5]
;
David F,Stroncek [5]
;
Nirali N,Shah [6]
;
Terry J,Fry [7]
;
Gaurav,Narula [3]
;
Rahul,Purwar [8]
作者单位：
Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay (IIT Bombay), Mumbai, Maharashtra, India.
[1]
Immunoadoptive Cell Therapy Private Limited (ImmunoACT Pvt Ltd), Mumbai, Maharashtra, India.
[2]
Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
[3]
Department of Transfusion Medicine, ACTREC, Tata Memorial Center, Navi Mumbai, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
[4]
Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Center for Cellular Engineering, Bethesda, Maryland.
[5]
Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
[6]
Department of Pediatrics, University of Colorado, Anschutz Medical Campus, Aurora, Colorado.
[7]
Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay (IIT Bombay), Mumbai, Maharashtra, India. purwarrahul@iitb.ac.in.
[8]
DOI
10.1158/1535-7163.MCT-20-0476
PMID
33632869
发布时间
2021-12-28
换一批
换一批
